Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal

Merck KGaA acquires Bio-Techne in $11 billion all-cash deal to bolster life sciences division

Merck KGaA has agreed to acquire Bio-Techne for approximately $11 billion in an all-cash deal, aiming to strengthen its life sciences portfo

GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade

GSK is in talks to acquire biotech firm Nuvalent for more than $9 billion, which would be its largest acquisition in over a decade and the s

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis

Myricx Bio, a cancer therapy spinout from the Francis Crick Institute and Imperial College London, has agreed to be acquired by Novartis in

AdBiotech Becomes No. 2 Shareholder of Pet Healthcare Firm Onhil

Christian Hackenberger on Tubulis: From academic startup to multibillion-dollar biotech acquisition

Christian Hackenberger, a chemist and founder of Tubulis, shares the story of how his academic startup grew into a multibillion-dollar acqui